Product Description

Buy Delatestryl in Canadian steroids shop. It’s convenient to pay with card.

Our bodybuilding store in Canada provides perfect quality Testosterone Enanthate for sale online. Maxtreme Pharma’s Testo-Enan-10 is top quality Testosterone Enanthate 250mg 10 ampoules (Delatestryl) from prominent anabolics manufacturer.

Our online pharmacy delivers Injectable Steroids across Canada, so we can ship your order to you fast, safe and discreet no matter where you live: Ontario, Quebec, Alberta, Nova Scotia, New Brunswick, Manitoba, British Columbia, Prince Edward Island, Saskatchewan, Newfoundland and Labrador. Please, use our United States shop for worldwide delivery. We offer reshipping policy for missing, seized or damaged parcels.

We are working as steroid suppliers since March 2009 and have great experience in catering steroids in Canada with full comfort for customers.

Our support department works 24/7 and always ready to answer any questions and solve any problems if such arise suddenly, all packages have tracking codes. We send notification emails for your order’s status change and you can always check current status via our special online service.

Testo-Enan-10 is widely known as Delatestryl, Testosterone Enanthate, Testoviron-250

In Canada there are alternate names for Testo-Enan-10 (Testosterone Enanthate): Maxtreme Pharma, Testosterone Enanthate, Testosterone Enanthate, Delatestryl 250mg ampoules, Testo-Enan-10 250mg ampoules.

All these are different names of the same substance – Testosterone Enanthate

Testosterone Enanthate Injection

Testosterone Enanthate Injection, provides testosterone enanthate, a derivative of the primary endogenous androgen testosterone.

Endogenous androgens are responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include growth and maturation of prostate, seminal vesicles, penis, and scrotum; development of male hair distribution, such as beard, pubic, chest, and axillary hair; laryngeal enlargement; vocal chord thickening; alterations in body musculature; and fat distribution.

Androgens also cause retention of nitrogen, sodium, potassium, and phosphorus, and decreased urinary excretion of calcium. Androgens have been reported to increase protein anabolism and decrease protein catabolism. Nitrogen balance is improved only when there is sufficient intake of calories and protein.

Androgens are responsible for the growth spurt of adolescence and for the eventual termination of linear growth which is brought about by fusion of the epiphyseal growth centers. In children, exogenous androgens accelerate linear growth rates but may cause a disproportionate advancement in bone maturation. Use over long periods may result in fusion of the epiphyseal growth centers and termination of the growth process. Androgens have been reported to stimulate the production of red blood cells by enhancing the production of erythropoietic stimulating factor.

During exogenous administration of androgens, endogenous testosterone release is inhibited through feedback inhibition of pituitary luteinizing hormone (LH). At large doses of exogenous androgens, spermatogenesis may also be suppressed through feedback inhibition of pituitary Follicle Stimulating Hormone (FSH).

There is a lack of substantial evidence that androgens are effective in fractures, surgery, convalescence, and functional uterine bleeding.

INDICATION

(Testosterone Enanthate Injection) is indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone.

Primary hypogonadism (congenital or acquired) – Testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, or orchidectomy.

Hypogonadotropic hypogonadism (congenital or acquired) – Idiopathic gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. (Appropriate adrenal cortical and thyroid hormone replacement therapy are still necessary, however, and are actually of primary importance.)

If the above conditions occur prior to puberty, androgen replacement therapy will be needed during the adolescent years for development of secondary sexual characteristics. Prolonged androgen treatment will be required to maintain sexual characteristics in these and other males who develop testosterone deficiency after puberty.

Delayed puberty – (Testosterone Enanthate Injection) may be used to stimulate puberty in carefully selected males with clearly delayed puberty. These patients usually have a familial pattern of delayed puberty that is not secondary to a pathological disorder; puberty is expected to occur spontaneously at a relatively late date. Brief treatment with conservative doses may occasionally be justified in these patients if they do not respond to psychological support. The potential adverse effect on bone maturation should be discussed with the patient and parents prior to androgen administration. An X-ray of the hand and wrist to determine bone age should be obtained every six months to assess the effect of treatment on the epiphyseal centers .

Females

Metastatic mammary cancer – (Testosterone Enanthate Injection) may be used secondarily in women with advancing inoperable metastatic (skeletal) mammary cancer who are one to five years postmenopausal. Primary goals of therapy in these women include ablation of the ovaries. Other methods of counteracting estrogen activity are adrenalectomy, hypophysectomy, and/or antiestrogen therapy. This treatment has also been used in premenopausal women with breast cancer who have benefited from oophorectomy and are considered to have a hormone-responsive tumor. Judgment concerning androgen therapy should be made by an oncologist with expertise in this field.